Neurological Surgery 脳神経外科52巻6号

2024年11月発行

特集 脳神経外科医が知っておくべき生活習慣病の最新治療

Ⅰ 総論

脳卒中と生活習慣病の関係

著者： 沓名章仁¹ 木村和美¹

所属機関： ¹日本医科大学脳神経内科

ページ範囲：P.1123 - P.1134

文献概要

Point
・生活習慣病と脳卒中の発症には関連があり，特に高血圧，糖尿病，脂質異常症と脳卒中発症との関連は大きい．
・時代背景の変化とともに生活習慣も変化しており，糖尿病，脂質異常症，肥満・メタボリックシンドロームは増加傾向にある．
・生活習慣病の早期診断・早期治療・指導により，脳卒中発症リスクを大幅に低減することができる．

参考文献

1）Hata J, et al：Secular trends in cardiovascular disease and its risk factors in Japanese：half-century data from the Hisayama Study（1961-2009）. Circulation 128：1198-1205, 2013

2）Yusuf S, et al：Modifiable risk factors, cardiovascular disease, and mortality in 155 722 individuals from 21 high-income, middle-income, and low-income countries（PURE）：a prospective cohort study. Lancet 395：795-808, 2020

3）Flint AC, et al：Effect of systolic and diastolic blood pressure on cardiovascular outcomes. N Engl J Med 381：243-251, 2019

4）Fujiyoshi A, et al：Blood pressure categories and long-term risk of cardiovascular disease according to age group in Japanese men and women. Hypertens Res 35：947-953, 2012

5）MacMahon S, et al：Blood pressure, stroke, and coronary heart disease. Part 1, Prolonged differences in blood pressure：prospective observational studies corrected for the regression dilution bias. Lancet 335：765-774, 1990

6）Fukuhara M, et al：Impact of lower range of prehypertension on cardiovascular events in a general population：the Hisayama Study. J Hypertens 30：893-900, 2012

7）Musini VM, et al：Pharmacotherapy for hypertension in adults aged 18 to 59 years. Cochrane Database Syst Rev 8：CD008276, 2017　doi:10.1002/14651858.CD008276.pub2

8）Musini VM, et al：Pharmacotherapy for hypertension in adults 60 years or older. Cochrane Database Syst Rev 6：CD000028, 2019　doi:10.1002/14651858.CD000028.pub3

9）厚生労働省：高血圧症有病者の状況．令和元年国民健康・栄養調査 第2部 身体状況調査の結果 第55表．2020　https://www.mhlw.go.jp/stf/seisakunitsuite/bunya/kenkou_iryou/kenkou/eiyou/r1-houkoku_00002.html

10）Xie X, et al：Effects of intensive blood pressure lowering on cardiovascular and renal outcomes：updated systematic review and meta-analysis. Lancet 387：435-443, 2016

11）厚生労働省：血圧の状況．令和元年国民健康・栄養調査 第2部 身体状況調査の結果 第22表．2020　https://www.mhlw.go.jp/stf/seisakunitsuite/bunya/kenkou_iryou/kenkou/eiyou/r1-houkoku_00002.html

12）Lau LH, et al：Prevalence of diabetes and its effects on stroke outcomes：a meta-analysis and literature review. J Diabetes Investig 10：780-792, 2019

13）Emerging Risk Factors Collaboration；Sarwar N, et al：Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease：a collaborative meta-analysis of 102 prospective studies. Lancet 375：2215-2222, 2010

14）Lee M, et al：Effect of pre-diabetes on future risk of stroke：meta-analysis. BMJ 344：e3564, 2012　doi:10.1136/bmj.e3564

15）Ikeda F, et al：Haemoglobin A1c even within non-diabetic level is a predictor of cardiovascular disease in a general Japanese population：the Hisayama Study. Cardiovasc Diabetol 12：164, 2013　doi:10.1186/1475-2840-12-164

16）厚生労働省：糖尿病の指摘の状況．令和元年国民健康・栄養調査 第2部 身体状況調査の結果 第50表．2020　https://www.mhlw.go.jp/stf/seisakunitsuite/bunya/kenkou_iryou/kenkou/eiyou/r1-houkoku_00002.html

17）厚生労働省：「糖尿病が強く疑われる者」及び「糖尿病の可能性を否定できない者」の状況．令和元年国民健康・栄養調査 第2部 身体状況調査の結果 第53表．2020　https://www.mhlw.go.jp/stf/seisakunitsuite/bunya/kenkou_iryou/kenkou/eiyou/r1-houkoku_00002.html

18）厚生労働省：糖尿病を指摘されたことがある者における治療の状況．令和元年国民健康・栄養調査 第2部 身体状況調査の結果 第51表．2020　https://www.mhlw.go.jp/stf/seisakunitsuite/bunya/kenkou_iryou/kenkou/eiyou/r1-houkoku_00002.html

19）Holman RR, et al：10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med 359：1577-1589, 2008

20）ACCORD Study Group；Gerstein HC, et al：Long-term effects of intensive glucose lowering on cardiovascular outcomes. N Engl J Med 364：818-828, 2011

21）UK Prospective Diabetes Study Group：Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes：UKPDS 38. BMJ 317：703-713, 1998

22）Colhoun HM, et al：Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study（CARDS）：multicentre randomised placebo-controlled trial. Lancet 364：685-696, 2004

23）Gaede P, et al：Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N Engl J Med 348：383-393, 2003

24）Ueki K, et al：Effect of an intensified multifactorial intervention on cardiovascular outcomes and mortality in type 2 diabetes（J-DOIT3）：an open-label, randomised controlled trial. Lancet Diabetes Endocrinol 5：951-964, 2017

25）Boysen G, et al：Stroke incidence and risk factors for stroke in Copenhagen, Denmark. Stroke 19：1345-1353, 1988

26）Blood pressure, cholesterol, and stroke in eastern Asia. Eastern Stroke and Coronary Heart Disease Collaborative Research Group. Lancet 352：1801-1807, 1998

27）Zhang X, et al：Cholesterol, coronary heart disease, and stroke in the Asia Pacific region. Int J Epidemiol 32：563-572, 2003

28）Cui R, et al：High serum total cholesterol levels is a risk factor of ischemic stroke for general Japanese population：the JPHC study. Atherosclerosis 221：565-569, 2012

29）Imamura T, et al：LDL cholesterol and the development of stroke subtypes and coronary heart disease in a general Japanese population：the Hisayama study. Stroke 40：382-388, 2009

30）Noda H, et al：Low-density lipoprotein cholesterol concentrations and death due to intraparenchymal hemorrhage：the Ibaraki Prefectural Health Study. Circulation 119：2136-2145, 2009

31）Briel M, et al：Effects of statins on stroke prevention in patients with and without coronary heart disease：a meta-analysis of randomized controlled trials. Am J Med 117：596-606, 2004

32）Baigent C, et al：Efficacy and safety of cholesterol-lowering treatment：prospective meta-analysis of data from 90, 056 participants in 14 randomised trials of statins. Lancet 366：1267-1278, 2005

33）Cholesterol Treatment Trialists'（CTT）Collaboration；Baigent C, et al：Efficacy and safety of more intensive lowering of LDL cholesterol：a meta-analysis of data from 170, 000 participants in 26 randomised trials. Lancet 376：1670-1681, 2010

34）Chou R, et al：Statins for prevention of cardiovascular disease in adults：evidence report and systematic review for the US Preventive Services Task Force. JAMA 316：2008-2024, 2016

35）Marston NA, et al：Association between triglyceride lowering and reduction of cardiovascular risk across multiple lipid-lowering therapeutic classes：a systematic review and meta-regression analysis of randomized controlled trials. Circulation 140：1308-1317, 2019

36）厚生労働省：血清LDLコレステロール値（直接法）の分布—血清LDLコレステロール値の区分，年齢階級別，人数，割合—男性・女性，20歳以上〔コレステロールを下げる薬又は中性脂肪（トリグリセライド）を下げる薬の使用者含む〕．令和元年国民健康・栄養調査 第2部 身体状況調査の結果 第36表の1．2020　https://www.mhlw.go.jp/stf/seisakunitsuite/bunya/kenkou_iryou/kenkou/eiyou/r1-houkoku_00002.html

37）厚生労働省：血清中性脂肪（トリグリセライド）値の分布−血清中性脂肪（トリグリセライド）値の区分，年齢階級別，人数，割合−男性・女性，20歳以上〔コレステロールを下げる薬又は中性脂肪（トリグリセライド）を下げる薬の使用者含む〕．令和元年国民健康・栄養調査 第2部 身体状況調査の結果 第39表の1．2020　https://www.mhlw.go.jp/stf/seisakunitsuite/bunya/kenkou_iryou/kenkou/eiyou/r1-houkoku_00002.html

38）Global Burden of Metabolic Risk Factors for Chronic Diseases Collaboration（BMI Mediated Effects）；Lu Y, et al：Metabolic mediators of the effects of body-mass index, overweight, and obesity on coronary heart disease and stroke：a pooled analysis of 97 prospective cohorts with 1・8 million participants. Lancet 383：970-983, 2014

39）Mitchell AB, et al：Obesity increases risk of ischemic stroke in young adults. Stroke 46：1690-1692, 2015

40）Li Y, et al：Body mass index and risks of incident ischemic stroke subtypes：the Japan Public Health Center-based prospective（JPHC）study. J Epidemiol 29：325-333, 2019

41）Iso H, et al：Metabolic syndrome and the risk of ischemic heart disease and stroke among Japanese men and women. Stroke 38：1744-1751, 2007

42）Niwa Y, et al：Association between stroke and metabolic syndrome in a Japanese population：Jichi Medical School（JMS）Cohort Study. J Epidemiol 20：62-69, 2010

43）厚生労働省：BMI・腹囲の分布．令和元年国民健康・栄養調査 第2部 身体状況調査の結果 第20表．2020　https://www.mhlw.go.jp/stf/seisakunitsuite/bunya/kenkou_iryou/kenkou/eiyou/r1-houkoku_00002.html

44）Shinton R, et al：Meta-analysis of relation between cigarette smoking and stroke. BMJ 298：789-794, 1989

45）Mannami T, et al：Cigarette smoking and risk of stroke and its subtypes among middle-aged Japanese men and women：the JPHC Study Cohort I. Stroke 35：1248-1253, 2004

46）Honjo K, et al：The effects of smoking and smoking cessation on mortality from cardiovascular disease among Japanese：pooled analysis of three large-scale cohort studies in Japan. Tob Control 19：50-57, 2010

47）Nakamura K, et al：Influence of smoking combined with another risk factor on the risk of mortality from coronary heart disease and stroke：pooled analysis of 10 Japanese cohort studies. Cerebrovasc Dis 33：480-491, 2012

48）Wannamethee SG, et al：Smoking cessation and the risk of stroke in middle-aged men. JAMA 274：155-160, 1995

49）Oono IP, et al：Meta-analysis of the association between secondhand smoke exposure and stroke. J Public Health（Oxf）33：496-502, 2011

50）Tan CE, et al：Association between smoke-free legislation and hospitalizations for cardiac, cerebrovascular, and respiratory diseases：a meta-analysis. Circulation 126：2177-2183, 2012

51）Camargo CA Jr：Moderate alcohol consumption and stroke. The epidemiologic evidence. Stroke 20：1611-1626, 1989

52）Iso H, et al：Alcohol consumption and risk ok stroke among middle-aged men：The JPHC study cohort Ⅰ. Stroke 35：1124-1129, 2004

53）Zhang C, et al：Alcohol intake and risk of stroke：a dose-response meta-analysis of prospective studies. Int J Cardiol 174：669-677, 2014

54）Inoue H, et al：Prevalence of atrial fibrillation in the general population of Japan：an analysis based on periodic health examination. Int J Cardiol 137：102-107, 2009

55）Tamaki K, et al：Trend in the prevalence of atrial fibrillation during the past 15 years in Iwate（Northeastern Area of Japan）. Circ J 81：1537-1539, 2017

56）Chung MK, et al：Lifestyle and risk factor modification for reduction of atrial fibrillation：a scientific statement from the American Heart Association. Circulation 141：e750-e772, 2020　doi:10.1161/CIR.0000000000000748